Skip to content

Prospective Pakistan Registry of Echocardiographic Screening in Asymptomatic Pregnant Women

Prospective Pakistan Registry of Echocardiographic Screening in Asymptomatic Pregnant Women

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06004544
Acronym
PRESAP
Enrollment
10000
Registered
2023-08-22
Start date
2023-02-06
Completion date
2028-12-31
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases in Pregnancy

Brief summary

Consecutive obstetric patients attending routine antenatal visits were enrolled in this ongoing registry. A standardized 2D transthoracic echocardiogram (TTE) protocol was employed. Ejection fraction (EF) was quantified using biplane Simpson's method.

Detailed description

Consecutive obstetric patients attending routine antenatal visits were enrolled in this ongoing registry. A standardized 2D transthoracic echocardiogram (TTE) protocol was employed, including parasternal long and short, apical 4- and 2-chamber views. Continuous wave and pulse wave Doppler were used to assess left ventricular outflow tract (LVOT) gradients. Left ventricular (LV) function was quantified using biplane Simpson's method and visually assessed by two independent readers. Patients with significant valve disease or congenital heart disease underwent complete TTE. Those diagnosed with LV dysfunction or other cardiovascular diseases (CVD) were referred to the Cardio-Obstetrics clinic for further management and long-term follow-up.

Interventions

None listed

Sponsors

Jinnah Postgraduate Medical Centre
CollaboratorOTHER_GOV
National Institute of Cardiovascular Diseases, Pakistan
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Obstetric patients attending routine antenatal visits

Exclusion criteria

* Patients refused to give consent for echocardiography or participation in the study

Design outcomes

Primary

MeasureTime frameDescription
Number of participants found to have abnormal left ventricular functionAt the time of screening echocardiogramPrevalence of Left ventricular dysfunction (Ejection Fraction\<55%)
Number of participants found to have abnormal heart valve functionAt the time of screening echocardiogramStructural heart abnormalities (valvular heart lesions classified as mild, moderate and severe)

Secondary

MeasureTime frameDescription
Number of participants found to have adverse Maternal outcomesAt the time of deliveryMaternal Mortality, Cardiogenic shock
Number of participants found to have adverse Fetal outcomesAt the time of deliveryInfant Mortality, Infant birth weight (kg)

Countries

Pakistan

Contacts

Primary ContactSabha Bhatti, MD
drsabhabhatti@gmail.com+92 335 5554346
Backup ContactShakeela Naz, FCPS
dr.shakeela7@gmail.com+92 331 3596502

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026